Questions
Evidence
Clinical Reference
Latest Research
About
EN
Login / Sign-up
Questions
Published answers connected to evidence
Evidence
Clinical Reference
Detailed intervention and outcome dossiers
Latest Research
Newest studies
About
How deDiabetes works
Settings
Language
EN
Theme
Light mode
Login / Sign-up
Evidence
/
Questions
Evidence Question
Do SGLT2 inhibitors lower All-cause mortality?
Related to: Cardiometabolic Risk
Short answer
SGLT2 inhibitors may lower All-cause mortality.
Explore the evidence
Open in Evidence Explorer
View Cardiometabolic Risk
